Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Gentian Diagnostics ASA ( (DE:6FK) ) has provided an announcement.
Gentian Diagnostics ASA has announced that its annual general meeting is scheduled for May 6, 2025, at its offices in Moss, Norway. This meeting is a standard procedure for the company, allowing shareholders to discuss and vote on various corporate matters, which may impact the company’s future strategies and operations.
More about Gentian Diagnostics ASA
YTD Price Performance: 13.12%
Technical Sentiment Signal: Strong Buy
Current Market Cap: €56.96M
Find detailed analytics on 6FK stock on TipRanks’ Stock Analysis page.